Related Experiment Video
Updated: Dec 3, 2025

Evaluation of Respiratory Muscle Activation Using Respiratory Motor Control Assessment RMCA in Individuals with Chronic Spinal Cord Injury
Published on: July 19, 2013
Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen
Marta Gómez-García de la Banda1,2,3, Alessandro Amaddeo4,5, Sonia Khirani4,5,6
1Pediatric Neurology and ICU Department, AP-HP Université Paris Saclay, DMU Santé de l'Enfant et de l'Adolescent, Hôpital Raymond Poincaré, Garches, France.
Insights
Nusinersen treatment significantly improved respiratory muscle strength and lung function in children with Spinal Muscular Atrophy (SMA) Type 2. Motor function also showed improvement, offering new hope for SMA patients.
Area of Science:
- Neurology
- Pediatrics
- Pulmonology
Background:
- Spinal Muscular Atrophy (SMA) is a genetic disorder affecting motor neurons.
- Nusinersen improves motor function in SMA but its effect on respiratory muscles is less understood.
- Respiratory muscle weakness is a major concern in SMA patients.
Purpose of the Study:
- To evaluate the impact of nusinersen on respiratory muscle performance and lung function in children with SMA Types 1c and 2.
- To compare respiratory muscle strength in nusinersen-treated SMA Type 2 patients with historical controls.
Main Methods:
- 16 children with SMA (2 Type 1c, 14 Type 2) received six nusinersen injections.
- Respiratory muscle strength was assessed using maximal static inspiratory pressure, forced vital capacity, and esophageal pressure.
- Motor function was evaluated using the Motor Function Measurement (MFM) and Hammersmith-Hine Scale (HINE-2) at baseline and 14 months.
- Data from treated SMA Type 2 patients were compared to 14 age-matched historical controls.
Main Results:
- Nusinersen-treated SMA Type 2 patients showed significantly improved inspiratory muscle strength compared to historical controls (p < .05).
- Improvements were noted in maximal static inspiratory pressure, forced vital capacity, and esophageal pressure during maximal sniff.
- Significant improvements in MFM and HINE-2 scores were observed in all 16 SMA patients after 14 months of nusinersen treatment.
Conclusions:
- Nusinersen treatment leads to significant improvements in respiratory muscle performance in children with SMA Type 2.
- The study demonstrates a positive effect of nusinersen on both respiratory and motor functions in pediatric SMA patients.
Introduction:
Nusinersen is associated with an improvement in motor function in children with spinal muscular atrophy (SMA) but data on respiratory muscles strength are scarce. Respiratory muscles performance and lung function were evaluated in children with SMA 1c and 2 after six injections of nusinersen (M14). Results from patients with SMA2 were compared with data of age-matched historical controls. Motor function tests (MFM and HINE-2) were assessed at baseline and M14 in the treated patients.
Results:
Sixteen children (2 SMA Type 1c and 14 SMA Type 2), mean age 9.4 ± 2.3 years, were included. The data of 14 historical SMA 2 controls (mean age 9.3 ± 1.9 years) were gathered. The strength of the global inspiratory muscles of SMA 2 treated with nusinersen, assessed on maximal static inspiratory pressure, forced vital capacity, and esophageal pressure during a maximal sniff was significantly better compared with historical controls (p < .05). A significant improvement in MFM and HINE-2 was observed in the patients with 16 SMA treated with nusinersen after 14 months as compared with baseline.
Conclusion:
In children with SMA Type 2, respiratory muscle performance was significantly better after six injections of nusinersen as compared with age-matched SMA Type 2 historical controls.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Related Concept Videos
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Skeletal Muscle Relaxants: Therapeutic Uses
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...